Panax notoginseng saponins ameliorate cisplatin‐induced mitochondrial injury via the HIF‐1α/mitochondria/ROS pathway

Qingqing Li,Xueyan Liang,Yufang Yang,Xian Zeng,Xiaobin Zhong,Chun Huang

DOI: https://doi.org/10.1002/2211-5463.12760

2019-12-05

FEBS Open Bio

Abstract:<p>Cisplatin is a major antineoplastic drug that is used to treat solid tumors, but its use is restricted by its nephrotoxicity. Such cisplatin‐induced nephrotoxicity (CIN) is believed to occur primarily through mitochondrial damage and ROS generation. Our previous studies have indicated that <i>Panax notoginseng</i> saponins (PNS) mitigate CIN by enhancing HIF‐1α‐induced mitochondrial autophagy. In this study, the role of the HIF‐1α/mitochondria/ROS pathway in PNS protection against CIN was investigated using a rat model. A CIN model was generated by giving rats intraperitoneal injections with cisplatin (a single dose), and then treating them with or without 2‐methoxyestradiol (2ME2) (HIF‐1α inhibitor) and PNS. We then measured ROS levels, SOD, GSH, CAT MDA and NO (to evaluate oxidative stress) and ATP, MMP and MPTP opening (to evaluate mitochondrial function) in kidneys at different time points. We observed that PNS remarkably reduced the levels of ROS, MDA and NO, as well as the opening of MPTP, which is increased by cisplatin and further increased by HIF‐1α inhibition. Additionally, PNS increased the levels of SOD, CAT and GSH, as well as ATP and MMP in renal tissues; these are all reduced by cisplatin and further reduced by HIF‐1α inhibition. In conclusion, we demonstrate here that PNS protects against mitochondrial damage induced by cisplatin through HIF‐1α/mitochondria/ROS.</p>

biochemistry & molecular biology